Log In
Print this Print this

BTCT4465A, RG7828

  Manage Alerts
Collapse Summary General Information
Company Genentech Inc.
DescriptionHumanized full-length T cell dependent bispecific antibody targeting CD20 and CD3
Molecular Target CD20 ; CD3
Mechanism of ActionBispecific antibody
Therapeutic ModalityBiologic: Antibody

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today